Download Slide 1

Blood borne viral hepatitis
action in Wales
Presenter: Dr Marion Lyons, BBV Lead for Wales
2010
Minister for Health
announces £1.377
recurrent funding
for Blood borne
viral Hepatitis
Action Plan for
Wales
Accountability
•
•
•
•
•
•
•
•
Welsh Assembly Government
Health Service Planners
Health Boards - NSE and health promotion
Health Boards - Primary Care
Health Boards – Treatment and care
Local Authorities
The National Offender Management Service
Non statutory organisations including patient
groups
• Public Health Wales
Structures
Prevention, education and
awareness raising
Harm reduction database
•
Lack of evidence re. prevalence of injecting drug use in Wales 
denominator data required for incidence and modelling potential
burden of disease
•
Evidence of ‘patchy’ NSP provision across Wales
•
Primary means of accessing, informing and preventing onward
transmission amongst most at risk groups
•
System live in statutory and voluntary sector needle exchange
services (including mobile services) 1st September 2010
•
To date over 2700 injectors registered
•
Next steps – roll out in community pharmacy based services
Prevention, education and
awareness raising
• Development of endorsed BBV training
programmes:
– Level 1 – all individuals working with
those currently or potentially at risk of
infection with blood borne viruses (HBV,
HCV and HIV)
– Level 2 – all individuals responsible for
diagnosing and treating individuals for
blood borne viruses
Prevention, education and
awareness raising
• Ongoing work focusing on:
– Improving BBV services for offender
populations in Wales
– Research project – ‘How best to
deliver health care messages re.
BBVs’
– Targeted and generic awareness
raising programme
Diagnosis & Surveillance
Dried blood spot testing (DBS)
– Pilot study in North West Wales CDT
– Means of testing for BBVs without need for
venepuncture (in first instance)
– Same protocol as utilised in prevalence
and incidence study 2005-2007 (700+
current IDUs)
– Improved uptake of testing amongst most
high risk groups
– Behavioural / risk behaviour questionnaire
to support evidence of transmission UK
wide
Diagnosis & Surveillance
• Strengthening of existing surveillance
systems – e.g. Co-surv
• Development of new patient
management tools
• Active case finding tools in primary care
• Data matrix available at:
http://www.wales.nhs.uk/sites3/page.cfm
?orgid=457&pid=25483
Treatment and care
pathways
• Each of seven treatment centres in
Wales develop local action plan
• Establishment of testing and
treatment in Community settings
e.g. Drug services, primary care
• Development of clinical networks
and consensus on treatment for
HBV and HCV
Stakeholder engagement
and events
• BBV workshop – 18th Nov 2010
• Aimed to identify existing best practice and areas
for improvement
• Opportunity to achieve consensus on treatment
for BBV hepatitis in Wales
– Lead clinicians from all treatment centres
in Wales
– BBV nurse specialists
– BBV Leads from all drug services
Stakeholder engagement
and events
• BBV Action in Wales Conference on
World Hepatitis Day July 2011
Open to all stakeholders and
interested parties
• Progress to date
• Areas for improvement
• Evaluation of interventions
• Next steps
Contact details
[email protected]
[email protected]
[email protected]
[email protected]
Copy of Action Plan available at:
http://wales.gov.uk/docs/phhs/publicatio
ns/100226actionplanen.pdf